The DOI matches its Crossref record.
Mechanism of hypertriglyceridaemia associated with contraceptive steroids.
Abstract
Plasma free fatty acid and triglyceride turnover rates were determined in thirty-five premenopausal adult healthy females. Eleven subjects were studied while taking a combined oestrogen-progestagen contraceptive preparation, seven women were taking either progesterone or megestrol alone, five women were taking an oestrogen preparation alone, and fifteen women served as controls. The plasma free fatty acid concentration and turnover rate were not affected by any of these steroids. The triglyceride concentration and turnover rate were increased in women taking either the combined preparation, or oestrogen alone. The intake of combined preparation was associated with increased clearance of both endogenous and exogenous triglycerides, though the post heparin plasma lipolytic activity was not altered. Women using either progesterone or megestrol showed a decrease in serum triglyceride concentration associated with both increased triglyceride clearance and increased activity of post-heparin plasma lipolytic activity. In this group, the triglyceride turnover rate was not affected. Women taking oestrogen alone had normal rates of clearance of plasma triglycerides. These results suggest that the increase in triglyceride turnover is the result of the oestrogenic component while the increase in triglyceride clearance is the net effect of the progestagen moiety. The changes in triglyceride turnover rate were significantly conelated with the duration of administration and the peak plasma insulin response to an oral glucose load.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral estrogens increase the hepatic secretion of VLDL, leading in turn to an increase in serum triglyceride levels (108).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [108]
Citations
Cited by
Sorted by citations
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
“Oral estrogens increase the hepatic secretion of VLDL, leading in turn to an increase in serum triglyceride levels (108).”
Role of Estrogens in the Regulation of Liver Lipid Metabolism
Palmisano, B. T., Zhu, L., & Stafford, J. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_12 · Cited by 577
“The progestin component of hormone treatment accelerates TG clearance and thus likely does not contribute to hypertriglyceridemia (Kissebah et al. 1973).”
BackgroundSex differences in lipid and lipoprotein metabolism
Palmisano, B. T., Zhu, L., Eckel, R. H., & Stafford, J. M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.008 · Cited by 551
“Progestins oppose the effect of estrogens by promoting VLDL clearance in both humans and animals ([105,106] and reviewed in [38]).”
BackgroundSex Differences in Lipid and Lipoprotein Metabolism: It's Not Just about Sex Hormones
Wang, X., Magkos, F., & Mittendorfer, B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2061 · Cited by 424
“The hypotriglyceridemic effect of progestogens is mediated by enhanced VLDL triglyceride and VLDL apolipoprotein B-100 plasma clearance rates (61, 78), whereas the HDL cholesterol-lowering effect is possibly associated with decreased production of HDL apolipoprotein A-I, which overcomes a simultaneous reduction in cle…”
Background
Metadata
- Authors
- Kissebah, A., Harrigan, P., & Wynn, V.
- Affiliations
- St Mary's Hospital (GB)
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 1973
- Volume
- 5
- Issue
- 03
- Pages
- 184-190
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W2067803293
- Cited by
- 106
- References
- 0
- Citations by year
- 2024: 1 · 2022: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2015: 1 · 2014: 1 · 2012: 1
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hormone and Metabolic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- hypertriglyceridemia, contraceptive steroids, progesterone, megestrol, estrogen, triglyceride turnover, triglyceride clearance, free fatty acids, insulin response, premenopausal women
- MeSH terms
- Adolescent, Adult, Body Weight, Carbon Isotopes, Contraceptives, Oral, Ethinyl Estradiol, Ethynodiol Diacetate, Fatty Acids, Nonesterified, Female, Heparin, Humans, Insulin Antibodies, Kinetics, Lipoproteins, VLDL, Megestrol, Mestranol, Norethindrone, Palmitic Acids, Progesterone, Time Factors, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review